NICE approves taxanes for breast cancer
White
Bmj 320(7251): 1688a
2000
ISSN/ISBN: 0959-8138 PMID: 10864529 Document Number: 520037
Document emailed within 1 workday
Related Documents
Kmietowicz, Z. 2000: NICE approves Taxol for ovarian cancer Bmj 320(7245): 1293Nabholtz, J.M. 1999: The role of taxanes in the management of breast cancer Seminars in Oncology 26(3 Suppl. 8): 1-3
O'Leary, J.; Volm, M.; Wasserheit, C.; Muggia, F. 1998: Taxanes in adjuvant and neoadjuvant therapies for breast cancer Oncology 12(1 Suppl 1: 23-27
Bozhok, A.A.; Semiglazov, V.F.; Kletzel', A.E.; Arzumanov, A.S.; Mel'nikova, O.A.; Paltuev, R.M.; Ivanova, O.A.; Semiglazov, V.V. 2006: Taxanes in neojuvant radio-, chemoradio- and chemotherapy for breast cancer Voprosy Onkologii 52(1): 7-14
Hsu, H-Chih.; Chang, H-Kun.; Lin, Y-Chang.; Hseu, S.; Chen, J-Shi.; Yang, T-Shen.; Wang, H-Ming.; Shen, W-Chi. 2009: The role of HER2 in metastatic breast cancer treated with a combination of taxanes and cisplatin Chang Gung Medical Journal 32(1): 33-41
Semiglazova, T.Iu.; Gershanovich, M.L. 2001: Xeloda (capecetabine) in the treatment of disseminated breast cancer after failure with anthracyclines and taxanes Voprosy Onkologii 47(3): 298-302
Wolff, A.C. 2005: Current status of taxanes as adjuvant therapy for early-stage breast cancer International Journal of Fertility and Women's Medicine 50(5 Pt 1): 227-229
Cocconi, G.; Salvagni, S.; Passalacqua, R.; Ferrozzi, F.; Camisa, R. 2004: Design and development of new combinations of the CMF agents with taxanes (paclitaxel or docetaxel) in advanced breast cancer: a feasibility study Tumori 90(3): 280-284
Bria, E.; Vanni, B.; Cuppone, F.; Calabretta, F.; Campanella, C.; Torsello, A.; Terzoli, E. 2004: Metastatic breast cancer: is global survival increase a realistic endpoint in phase III clinical trials? Studies on taxanes; studies on trastuzumab I Supplementi di Tumori: Official Journal of Societa Italiana di Cancerologia . 3(4): S65-S66
Espié, M.; Cuvier, C.; Gorins, A.; Marty, M. 1998: Taxanes in the treatment of breast and ovarian cancers: current indications and results Contraception Fertilite Sexualite 26(11): 805-811
Fletcher, P. 2000: Do NICE and CHI have no interest in safety? Opinion of the book NICE, CHI and the NHS reforms. Enabling excellence or imposing control? Adverse Drug Reactions and Toxicological Reviews 19(3): 167-176
Lipkus, I.M.; Iden, D.; Terrenoire, J.; Feaganes, J.R. 1999: Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 8(6): 533-539
Rawlins, M.D. 2001: The failings of NICE. Reply from chairman of NICE Bmj 322(7284): 489
1997: Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium Lancet 349(9064): 1505-1510
Saif, M.Wasif. 2013: U.S. Food and Drug Administration approves paclitaxel protein-bound particles (Abraxane®) in combination with gemcitabine as first-line treatment of patients with metastatic pancreatic cancer Jop: Journal of the Pancreas 14(6): 686-688
Reiner, A.S.; Sisti, J.; John, E.M.; Lynch, C.F.; Brooks, J.D.; Mellemkjær, L.; Boice, J.D.; Knight, J.A.; Concannon, P.; Capanu, M.; Tischkowitz, M.; Robson, M.; Liang, X.; Woods, M.; Conti, D.V.; Duggan, D.; Shore, R.; Stram, D.O.; Thomas, D.C.; Malone, K.E.; Bernstein, L.; Bernstein, J.L. 2018: Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women's Environmental Cancer and Radiation Epidemiology Study Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 36(15): 1513-1520
Nabholtz, J.M.; Lindsay, M.A.; Hugh, J.; Mackey, J.; Smylie, M.; Au, H.J.; Tonkin, K.; Allen, M. 1999: The academic global virtual concept in clinical cancer research and its application to breast cancer: The Breast Cancer International Research Group Seminars in Oncology 26(3 Suppl. 8): 4-8
Albeshan, S.M.; Hossain, S.Z.; Mackey, M.G.; Brennan, P.C. 2020: Can Breast Self-examination and Clinical Breast Examination Along with Increasing Breast Awareness Facilitate Earlier Detection of Breast Cancer in Populations with Advanced Stages at Diagnosis? Clinical Breast Cancer 20(3): 194-200
Mariuzzi, L.; Mombello, A.; Rucco, V.; Morelli, L.; Zamò, A.; Thompson, D.; Vaught, L.; Bartels, H.G.; Mariuzzi, G.; Bartels, P.H. 2000: Quantitative study of ductal breast cancer progression: signatures of nuclei in proliferating breast lesions and in situ cancer Advances in Clinical Pathology: the Official Journal of Adriatic Society of Pathology 4(2): 87-97
Rosenberg, L.; Palmer, J.R.; Shapiro, S. 1992: Oestrogen replacement therapy and breast cancer Results from the Slone Epidemiology Units Toronto Breast Cancer Study Mann, R D Hormone replacement therapy and breast cancer risk : 253-264